Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
2017 · Cell Reports · 194 citations
https://doi.org/10.1016/j.celrep.2017.11.003
M
Martin Bigonnet
Predict (France)(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
59
Papers
1.3K
Citations
16
h-index
21
i10-index
Martin Bigonnet is an academic researcher from Predict (France). The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Cancer Cells and Metastasis. The author has an h-index of 16, co-authored 51 publications.
ORCID: 0000-0001-5652-3132Papers by this author
worksA transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
2020 · Annals of Oncology · 79 citations
https://doi.org/10.1016/j.annonc.2020.10.601
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
2020 · EBioMedicine · 77 citations
https://doi.org/10.1016/j.ebiom.2020.102858
Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the <scp>BET</scp> bromodomain inhibitor <scp>JQ</scp> 1: implications for individualized medicine efforts
2017 · EMBO Molecular Medicine · 68 citations
https://doi.org/10.15252/emmm.201606975
Development and validation of AI-assisted transcriptomic signatures to personalize adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma
2024 · Annals of Oncology · 27 citations
https://doi.org/10.1016/j.annonc.2024.06.010
Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction
2022 · npj Precision Oncology · 23 citations
https://doi.org/10.1038/s41698-022-00299-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat